Rosetta Licenses the Rosetta Resolver System to the FGCZ
News Nov 22, 2005
Rosetta Biosoftware has announced that the Functional Genomics Center of Zurich, Switzerland (FGCZ) licensed the Rosetta Resolver system.
The FGCZ will use the Resolver system to analyze and store cross-platform microarray data generated from the hundreds of regional functional genomic projects supported by the expert institution.
"Rosetta Biosoftware is pleased to provide the FGCZ with a flexible and integrated informatics solution that will guarantee consistency and quality for their gene expression research," said Yelena Shevelenko, vice president and general manager of Rosetta Biosoftware.
"The Resolver system provides advanced tools for raw and analytical gene expression data management."
"The cross-species and cross-platform analysis tools in the system will help the FGCZ advance their research in transcriptomics."
"We are pleased to add the Resolver system to our strong portfolio of analytical resources for conducting genome-wide, high-resolution gene expression analysis," said Dr. Ralph Schlapbach, managing director of the FGCZ.
"The central database and standardized statistical tools will enable all our users to efficiently analyze microarray data for differential expression."
Bioethics Council Rules Heritable Genome Editing "Ethically Acceptable" In Certain CircumstancesNews
A leading UK bioethics advisory body has weighed in on the debate around human genetic modification, concluding that heritable genome editing – modifying the DNA of an egg, sperm or embryo with changes that will be passed on to future generations – could be ‘morally permissible’ in humans, provided key ethical tests are met.
Genetic Factors Leading to Rare Bone Fusion Disorder IdentifiedNews
Genome sequencing establishes multiple genes responsible for a rare condition that cause bone fusionREAD MORE
Hay Fever Risk Genes Overlap with Autoimmune DiseaseNews
In a large international study involving almost 900,000 participants, researchers from the University of Copenhagen and COPSAC have found new risk genes for hay fever. It is the largest genetic study so far on this type of allergy, which affects millions of people around the world.READ MORE